JP2022500445A5 - - Google Patents

Info

Publication number
JP2022500445A5
JP2022500445A5 JP2021514324A JP2021514324A JP2022500445A5 JP 2022500445 A5 JP2022500445 A5 JP 2022500445A5 JP 2021514324 A JP2021514324 A JP 2021514324A JP 2021514324 A JP2021514324 A JP 2021514324A JP 2022500445 A5 JP2022500445 A5 JP 2022500445A5
Authority
JP
Japan
Prior art keywords
compound
itching
treatment
neuropathic pain
skin disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021514324A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022500445A (ja
JP7353663B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/074465 external-priority patent/WO2020053377A1/en
Publication of JP2022500445A publication Critical patent/JP2022500445A/ja
Publication of JP2022500445A5 publication Critical patent/JP2022500445A5/ja
Application granted granted Critical
Publication of JP7353663B2 publication Critical patent/JP7353663B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021514324A 2018-09-13 2019-09-13 Gabaa受容体リガンド Active JP7353663B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18194297 2018-09-13
EP18194297.0 2018-09-13
PCT/EP2019/074465 WO2020053377A1 (en) 2018-09-13 2019-09-13 A gabaa receptor ligand

Publications (3)

Publication Number Publication Date
JP2022500445A JP2022500445A (ja) 2022-01-04
JP2022500445A5 true JP2022500445A5 (https=) 2022-10-17
JP7353663B2 JP7353663B2 (ja) 2023-10-02

Family

ID=63579205

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021514324A Active JP7353663B2 (ja) 2018-09-13 2019-09-13 Gabaa受容体リガンド

Country Status (24)

Country Link
US (1) US11396510B2 (https=)
EP (1) EP3849976B1 (https=)
JP (1) JP7353663B2 (https=)
KR (1) KR102712565B1 (https=)
CN (1) CN112714765B (https=)
AU (1) AU2019338236B2 (https=)
BR (1) BR112021004661A2 (https=)
CA (1) CA3110283A1 (https=)
DK (1) DK3849976T3 (https=)
EA (1) EA202190717A1 (https=)
ES (1) ES2935705T3 (https=)
FI (1) FI3849976T3 (https=)
HR (1) HRP20230067T1 (https=)
HU (1) HUE060943T2 (https=)
IL (1) IL281335B2 (https=)
LT (1) LT3849976T (https=)
MX (1) MX2021003010A (https=)
PH (1) PH12021550299A1 (https=)
PL (1) PL3849976T3 (https=)
PT (1) PT3849976T (https=)
SG (1) SG11202101360VA (https=)
SI (1) SI3849976T1 (https=)
WO (1) WO2020053377A1 (https=)
ZA (1) ZA202100976B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240197733A1 (en) 2021-04-16 2024-06-20 Saniona A/S A gaba receptor modulator for use in the treatment of pain
CN121793968A (zh) * 2023-09-15 2026-04-03 萨尼奥纳有限责任公司 一种用于治疗失神发作的gaba受体调节剂
CN121793969A (zh) * 2023-09-15 2026-04-03 萨尼奥纳有限责任公司 一种用于治疗与睡眠纺锤波缺陷相关的疾病的gaba受体调节剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU675484B2 (en) 1993-03-24 1997-02-06 Neurosearch A/S Benzimidazole compounds, their use and preparation
GB9702524D0 (en) * 1997-02-07 1997-03-26 Merck Sharp & Dohme Therapeutic agents
GB9813576D0 (en) * 1998-06-24 1998-08-19 Merck Sharp & Dohme Therapeutic agents
ATE284403T1 (de) 1999-01-27 2004-12-15 Merck Sharp & Dohme Triazolopyridazinderivate als liganden für gaba- rezeptoren
GB9921150D0 (en) * 1999-09-07 1999-11-10 Merck Sharp & Dohme Therapeutic agents
GB0208394D0 (en) * 2002-04-11 2002-05-22 Merck Sharp & Dohme Therapeutic agents
GB0208392D0 (en) 2002-04-11 2002-05-22 Merck Sharp & Dohme Therapeutic compounds
GB0212048D0 (en) * 2002-05-24 2002-07-03 Merck Sharp & Dohme Therapeutic agents
EP1613618A2 (en) 2003-04-03 2006-01-11 Neurosearch A/S BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABA- sb A /sb RECEPTOR COMPLEX
TWI391381B (zh) * 2006-03-24 2013-04-01 Neurosearch As 新穎的苯并咪唑衍生物、含有其之醫藥組成物、及其於製造藥物之用途
TW201029986A (en) 2008-11-14 2010-08-16 Neurosearch As Novel compounds
WO2017129801A1 (en) 2016-01-27 2017-08-03 Universität Zürich Use of gabaa receptor modulators for treatment of itch

Similar Documents

Publication Publication Date Title
JP2024071370A5 (https=)
JP2024516371A5 (https=)
JP2021063088A5 (https=)
JP2023002662A5 (https=)
JP2025013344A5 (https=)
JP2021098728A5 (https=)
JP2023126440A5 (https=)
JP2018518537A5 (https=)
JP2022500445A5 (https=)
JP2022191257A5 (https=)
JP2022515293A5 (https=)
JPWO2023195530A5 (https=)
JP2024512425A5 (https=)
JP2024528127A5 (https=)
JP2018145180A5 (https=)
JP2015510916A5 (https=)
JP2023116697A5 (https=)
JP2019151627A5 (https=)
JP2018522875A5 (https=)
JP2018531273A5 (https=)
JP2015516419A5 (https=)
MX2024014315A (es) Compuestos amido heteroaromaticos utiles en el tratamiento de enfermedades hepaticas
JP2019218379A5 (https=)
JP2023553253A5 (https=)
FI3849976T3 (fi) Gaba a -reseptorin ligandi